X-143517361-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001009609.4(SPANXN3):c.31G>A(p.Glu11Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00026 in 1,209,662 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 90 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001009609.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000161 AC: 18AN: 111678Hom.: 0 Cov.: 22 AF XY: 0.0000591 AC XY: 2AN XY: 33842
GnomAD3 exomes AF: 0.0000818 AC: 15AN: 183266Hom.: 0 AF XY: 0.0000591 AC XY: 4AN XY: 67704
GnomAD4 exome AF: 0.000270 AC: 296AN: 1097984Hom.: 0 Cov.: 30 AF XY: 0.000242 AC XY: 88AN XY: 363360
GnomAD4 genome AF: 0.000161 AC: 18AN: 111678Hom.: 0 Cov.: 22 AF XY: 0.0000591 AC XY: 2AN XY: 33842
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.31G>A (p.E11K) alteration is located in exon 1 (coding exon 1) of the SPANXN3 gene. This alteration results from a G to A substitution at nucleotide position 31, causing the glutamic acid (E) at amino acid position 11 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at